| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |